Casdin Capital, LLC Denali Therapeutics Inc. Transaction History

Casdin Capital, LLC

$1.16 Billion
Q4 2024

A detailed history of Casdin Capital, LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 990,000 shares of DNLI stock, worth $16.1 Million. This represents 1.74% of its overall portfolio holdings.

Number of Shares

990,000

Previous 990,000 -0.0%

Holding current value

$16.1 Million

Previous $28.8 Million 30.04%

% of portfolio

1.74%

Previous 2.24%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$20.96 - $31.05 $6.5 Million - $9.63 Million	-310,000 Reduced 23.85%	990,000 $28.8 Million
Q4 2022 Feb 14, 2023	BUY	$26.28 - $33.92 $8.02 Million - $10.3 Million	305,000 Added 30.65%	1,300,000 $36.2 Million
Q3 2022 Nov 14, 2022	SELL	$25.97 - $38.53 $13.1 Million - $19.5 Million	-505,000 Reduced 33.67%	995,000 $30.5 Million
Q4 2021 Feb 14, 2022	SELL	$42.59 - $55.02 $8.52 Million - $11 Million	-200,000 Reduced 11.76%	1,500,000 $66.9 Million
Q3 2021 Nov 15, 2021	BUY	$48.48 - $78.23 $4.36 Million - $7.04 Million	90,000 Added 5.59%	1,700,000 $85.8 Million
Q1 2021 May 17, 2021	BUY	$53.8 - $81.53 $16.1 Million - $24.5 Million	300,000 Added 22.9%	1,610,000 $91.9 Million
Q2 2020 Aug 14, 2020	SELL	$16.01 - $28.82 $2.32 Million - $4.18 Million	-145,000 Reduced 9.97%	1,310,000 $31.7 Million
Q1 2020 May 15, 2020	BUY	$14.2 - $27.98 $2.91 Million - $5.74 Million	205,000 Added 16.4%	1,455,000 $25.5 Million
Q4 2019 Feb 14, 2020	BUY	$14.4 - $19.99 $8.64 Million - $12 Million	600,000 Added 92.31%	1,250,000 $21.8 Million
Q3 2019 Jan 03, 2020	BUY	$15.32 - $21.92 $3.83 Million - $5.48 Million	250,000 Added 62.5%	650,000 $9.96 Billion
Q3 2019 Nov 12, 2019	SELL	$15.32 - $21.92 $3.83 Million - $5.48 Million	-250,000 Reduced 38.46%	400,000 $8.3 Billion
Q3 2019 Nov 12, 2019	BUY	$15.32 - $21.92 $3.83 Million - $5.48 Million	250,000 Added 62.5%	650,000 $9.96 Billion
Q2 2019 Aug 13, 2019	BUY	$18.5 - $28.14 $5.55 Million - $8.44 Million	300,000 Added 300.0%	400,000 $0
Q4 2018 Feb 13, 2019	BUY	$13.88 - $21.75 $1.39 Million - $2.18 Million	100,000 New	100,000 $2.07 Million

Others Institutions Holding DNLI

# of Institutions

240

Shares Held

121M

Call Options Held

80K

Put Options Held

36.8K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.19B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Casdin Capital, LLC with notifications on news.

Account

Casdin Capital, LLC Denali Therapeutics Inc. Transaction History